Clinical trial
Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental…
NCT00377117 · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Other · Completed
Key facts
| NCT number | NCT00377117 |
|---|---|
| Title | Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population Part II |
| Official title | Diabetes Screening, Risk Management, and Disease Management in a High-Risk Mental Health Population. |
| Lead sponsor | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Other |
| Collaborators | Eli Lilly and Company Industry St. Joseph's Health Care London |
| Status | Completed |
| Study type | Observational |
| Conditions | Diabetes Mellitus, Schizophrenia, Psychotic Disorders |
| Intervention type | Procedure |
| Interventions | Management, Screening |
| Enrollment | 39 |
| Start date | May 1, 2006 |
| Completion | Jul 1, 2007 |
| First posted | Sep 15, 2006 |
| Last update posted | Nov 6, 2018 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: